Synthesis and characterization of a diruthenium-ibuprofenato complex - Comparing its anti-inflammatory activity with that of a copper(II)- ibuprofenato complex

Journal of Inorganic Biochemistry

Volumn 81, Issue 1-2, 2000, Pages 23-27

  Andrade, A ^a   Namora, S F ^a   Woisky, R G ^a   Wiezel, G ^a   Najjar, R ^a   Sertie J A A ^a   De Oliveira Silva, D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti inflammatory; Copper(II); Diruthenium(II,III); Gastrotoxicity; Ibuprofen

Indexed keywords

CARRAGEENAN; COPPER COMPLEX; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; RUTHENIUM COMPLEX;

ABSORPTION SPECTROSCOPY; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPLEX FORMATION; DRUG EFFECT; GASTROINTESTINAL TOXICITY; MALE; NONHUMAN; PAW EDEMA; RAT; SYNTHESIS; THERMOGRAVIMETRY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; EDEMA; GASTROINTESTINAL HEMORRHAGE; IBUPROFEN; INDICATORS AND REAGENTS; MALE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; STOMACH DISEASES; STOMACH ULCER; STRESS, PSYCHOLOGICAL;

ANIMALIA;

EID: 0034661023     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(00)00106-9     Document Type: Article

References (30)

1. Sorenson J.R.J. Sorenson J.R.J. Biology of Copper Complexes. 1987;243-257 Humana Press, New York.
2. Sorenson J.R.J. Inorg. Chim. Acta. 91:1984;285.
3. Oga S., Taniguchi S.F., Najjar R., Souza A.R. J. Inorg. Biochem. 41:1991;45.
4. Keppler B.K., Lipponer K., Stenzel B., Kratz F. Keppler B.K. Metal Complexes in Cancer Chemotherapy. 1993;187-220 VCH, New York.
5. Glosh L.K., Glosh N.C., Chatterjee M., Gupta B.K. Drug Dev. Ind. Pharm. 24:1998;473.
6. Harris R.E., Kasbari S., Farrar W.B. Oncol. Rep. 6:1999;71.
7. Hida T., Leyton J., Makheja A.N., Ben-Av P., Hla T., Martinez A., Mulshine J., Malkani S., Chung P., Moody T.W. Anticancer Res. 18:1998;775.
8. Dendrinou-Samara C., Tsotsou G., Ekateriniadou L.V., Kortsaris A.H., Raptopoulou C.P., Terzis A., Kyriakidis D.A., Kessissoglou D.P. J. Inorg. Biochem. 71:1998;171.
9. Melnik M. Coord. Chem. Rev. 36:1981;1.
10. Kato M., Muto Y. Coord. Chem. Rev. 92:1988;45.
11. Cotton F.A., de Oliveira Silva D. Inorg. Chim. Acta. 249:1996;57.
12. Carvill A., Higgins P., McCann M., Ryan H., Shiels A. J. Chem. Soc. Dalton Trans. 1989;2435.
13. Frazier D.R., Lynch S.K., Carlisle G.O. J. Inorg. Nucl. Chem. 43:1981;2747.
14. Abuhijleh A.L. J. Inorg. Biochem. 55:1994;255.
15. Abuhijleh A.L. Polyhedron. 16:1997;733.
16. Sem S.E., Anliker K.S. J. Chem. Educ. 73:1996;569.
17. Mitchell R.W., Spencer A., Wilkinson G. J. Chem. Soc. Dalton Trans. 1973;846.
18. Swingle K.F. Arch. Int. Pharmacodyn. 222:1976;132.
19. Winder C.V., Max J., Been M.A. Arch. Int. Pharmacodyn. 112:1957;174.
20. Basile A.C., Sertié J.A.A., Panizza S., Oshiro T.T., Azzolini C.A. J. Ethnopharmacol. 30:1990;185.
21. Szelenyi I., Thiemer K. Arch. Toxicol. 41:1978;99.
22. Sokal R.R., Rohlf F.J. Biometry. 1969;776 Freeman, San Francisco.
23. Miskowski V.M., Gray H.B. Inorg. Chem. 27:1988;2501.
24. Geary W.J. Coord. Chem. Rev. 7:1971;81.
25. Tesler J., Drago R.S. Inorg. Chem. 23:1984;3114.
26. Deacon G.B., Heber F. Inorg. Chim. Acta. 104:1985;41.
27. Agterberg F.P.W., Provó-Kluit H.A.J., Driessen W.L., Oevering H., Buijs W., Lakin M.T., Spek A.L., Reedijk J. Inorg. Chem. 36:1997;4321.
28. Willians D.A., Walz D.R., Foye W.O. J. Pharm. Sci. 65:1976;126.
29. Rainsford K.D., Whitehouse M.W. Experientia. 32:1976;1172.
30. Boyle E., Freeman P.C., Goudie A.C., Magan F.R., Thompson M. J. Pharm. Pharmacol. 28:1976;865.